KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $299.0 million.

  • Medtronic's Change in Inventory rose 39016.39% to $299.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $686.0 million, marking a year-over-year increase of 44472.36%. This contributed to the annual value of $292.0 million for FY2025, which is 11007.19% up from last year.
  • According to the latest figures from Q4 2025, Medtronic's Change in Inventory is $299.0 million, which was up 39016.39% from $373.0 million recorded in Q3 2025.
  • In the past 5 years, Medtronic's Change in Inventory registered a high of $410.0 million during Q3 2023, and its lowest value of -$391.0 million during Q2 2024.
  • Its 5-year average for Change in Inventory is $119.0 million, with a median of $176.0 million in 2023.
  • As far as peak fluctuations go, Medtronic's Change in Inventory soared by 40666.67% in 2022, and later crashed by 1313333.33% in 2024.
  • Over the past 5 years, Medtronic's Change in Inventory (Quarter) stood at $81.0 million in 2021, then soared by 398.77% to $404.0 million in 2022, then tumbled by 49.01% to $206.0 million in 2023, then crashed by 70.39% to $61.0 million in 2024, then soared by 390.16% to $299.0 million in 2025.
  • Its Change in Inventory was $299.0 million in Q4 2025, compared to $373.0 million in Q3 2025 and -$186.0 million in Q2 2025.